About: Modotuximab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Modotuximab (INN; formerly zatuximab) is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER1.

Property Value
dbo:abstract
  • Modotuximab (INN; formerly zatuximab) is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER1. (en)
dbo:casNumber
  • 1310460-86-6
dbo:fdaUniiCode
  • 1W7BD1M08N
dbo:kegg
  • D11125
dbo:wikiPageID
  • 38271070 (xsd:integer)
dbo:wikiPageLength
  • 1501 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 981899001 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:casNumber
  • 1310460 (xsd:integer)
dbp:chemspiderid
  • none (en)
dbp:kegg
  • D11125 (en)
dbp:mabType
  • mab (en)
dbp:source
  • xi (en)
dbp:target
dbp:type
  • mab (en)
dbp:unii
  • 1 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Modotuximab (INN; formerly zatuximab) is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER1. (en)
rdfs:label
  • Modotuximab (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License